Search

Search Results

2 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 13, Issue 5pp 6890-6903

  MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts

  Relevance score: 0.00

  Kaibin Zhu, Zhonghua Lv, Jinsheng Xiong, Hongshan Zheng, Sibin Zhang, Hua Jin, Lei Yu, Zhenzhe Li, Jixing Zhang, Chenlong Li, Peng Liang

  Keywords: osimertinib resistance, non-small cell lung cancer (NSCLC), cancer-associated fibroblasts (CAFs), MET associated signaling, capmatinib

  Published in Aging on February 17, 2021

  Show abstract
• Research PaperVolume 12, Issue 9pp 8001-8015

  Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer

  Relevance score: 0.00

  Qinfang Deng, Qiyu Fang, Boxiong Xie, Hui Sun, Yuchen Bao, Songwen Zhou

  Keywords: non-small cell lung cancer, exosomes, epidermal growth factor receptor, long non-coding RNAs, osimertinib resistance

  Published in Aging on May 6, 2020

  Show abstract